Immune Responses in Tissues

Chapter 12 Immune Responses in Tissues





Tissue-specific immune responses


What determines whether an immune response should be comprised of, for example, activated cytotoxic T lymphocytes (CTLs) or a particular class of antibodies? Although immune responses are primarily tailored to the pathogen, there is also a strong influence from the local tissue, where the immune response occurs (Fig. 12.1).



This chapter focuses on:



There are several reasons why a particular organ may need to modify local immunity.



This is an example of how an immune response summoned to clear an infection can interfere with a tissue’s physiology as seriously as the infection itself. A similar outcome can occur in both the eye and the gut, which may be damaged by cytokines such as tumor necrosis factor-α (TNFα) and interferon-γ (IFNγ) produced locally during cell-mediated immune reactions.


Indeed, when TNFα and IFNγ reach high systemic levels, they can result in shock and rapid death. An example is seen in Dengue shock syndrome. Individuals who are immune to the Dengue virus or infants with maternal antibodies may develop rapid circulatory collapse. It is thought that interaction between activated T cells and macrophages causes the release of TNFα, which acts on endothelium leading to an increase in capillary permeability and consequent fall in blood pressure.


Moreover, some types of immune response are only appropriate in specific tissues.



These observations suggest that the immune responses in tissues are modulated in order to be appropriate for and effective at that site. Consequently, tissues have evolved regulatory mechanisms that influence the immune response that occurs within them.




Endothelium controls which leukocytes enter a tissue


Migration of leukocytes into different tissues of the body is dependent on the vascular endothelium in each tissue. For many years, it was thought that the endothelium in different tissues was essentially similar, with the possible exception of tissues such as the brain and retina, which have barrier properties (see below). Despite this common belief, it was well known that inflammation in different tissues had different characteristics, even when the inducing agents were similar.


It is now clear that a major element controlling inflammation and the immune response is the vascular endothelium in each tissue, which has its own characteristics; different endothelia produce distinctive blends of chemokines (Fig. 12.2). In addition the endothelium can transport chemokines produced by cells in the tissue from the basal to the lumenal surface by transcytosis, or by surface diffusion in tissues that lack barrier properties (Fig. 12.3).




The surface (glycocalyx) of vascular endothelium also varies considerably between tissues, and this affects which chemokines are retained on the lumenal surface, to signal to circulating leukocytes.



Hence the different sets of leukocytes present in each tissue can be partly related to the chemokines synthesized by the cells present, particularly the endothelium. For example, in normal lung there is a high level of macrophage migration, which relates to the high expression of CCL2 (macrophage chemotactic protein-1) by lung endothelium. In allergic asthma, the proportion of eosinophils increases, due to the production of IL-5 and CCL3 (eotaxin), which are characteristic of the TH2 response that tends to predominate in mucosal tissues (Fig. 12.4). By contrast, in the CNS lymphocytes and mononuclear phagocytes predominate in most immune reactions.






Immune reactions in the CNS


The CNS, including the brain, spinal cord, and retina of the eye is substantially shielded from immune reactions. The peripheral nervous system is also partially protected. The low levels of immune reactivity in the brain are ascribed to a number of factors:




The blood–brain barrier excludes most antibodies from the CNS


The blood–brain barrier is a composite structure formed by the specialized brain endothelium and the foot processes of astrocytes. Astrocytes are required to induce the special properties of brain endothelial cells, which have continuous belts of tight junctions connecting them to other endothelial cells (Fig. 12.5). An estimate of the tightness of the barrier is given by its trans-endothelial resistance, which is up to 2000 Ω/cm2 in the CNS by comparison with values <10 Ω/cm2 in most other tissues. In addition the brain endothelial cells have an array of transporters that allow nutrients into the CNS and a set of multi-drug resistance pumps that prevent many toxic molecules and therapeutic drugs from entering the brain. However, it is the very low permeability of the endothelium to serum proteins which is of particular interest for immunologists (see Fig. 12.5). For example, the level of IgG found in the CNS is normally approximately 0.2% of the level found in serum. The level may rise during an immune reaction as the endothelial barrier becomes more permeable in response to inflammatory cytokines. In some conditions, such as multiple sclerosis, there is often local synthesis of antibody within the CNS, which is reflected in abnormally high antibody levels in cerebrospinal fluid, even accounting for the increased leakage into the CNS. This finding demonstrates that some B cells have migrated into the CNS, and plasma cells have been identified in the spaces surrounding the larger blood vessels. Macrophages also contribute to immune reactions in CNS and they can synthesize some complement components locally (e.g. C3). However the overall level of serum proteins including antibodies and complement rarely exceeds 2% of the levels in serum even in the most severe inflammatory reactions.



Jun 18, 2016 | Posted by in IMMUNOLOGY | Comments Off on Immune Responses in Tissues

Full access? Get Clinical Tree

Get Clinical Tree app for offline access